Concepedia

Jan Vågberg

JV

Statistics

Publications

3

Citations

133

H-Index

3

Active since

2018

Affiliations

Kancera (Sweden)(Current)

Karolinska Institutet

Karolinska University Hospital

Semnan University of Medical Sciences

Jan Vågberg is an author at Kancera (Sweden) specializing in medicine, tyrosine kinase inhibitors, and oncology.

Publications per year

2018–2020

3

Publications

3

First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells

Mohammad Hojjat‐Farsangi, Amir Hossein Daneshmanesh, Abdul Salam Khan et al. · Leukemia · 2018 · 52 citations · Full text

, , +16

A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib

Amir Hossein Daneshmanesh, Mohammad Hojjat‐Farsangi, Amineh Ghaderi et al. · PLoS ONE · 2018 · 43 citations · Full text

, , +17

ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells

Amineh Ghaderi, Amir Hossein Daneshmanesh, Ali Moshfegh et al. · Biomedicines · 2020 · 38 citations · Full text

, , +14

1–3 of 3